FDA calendar · July 2021 · built from SEC filings

PDUFA dates July 2021: FDA calendar and catalysts.

Updated Snapshot 20261116T222116ZBuilt

0 PDUFA dates fell in July 2021. The FDA calendar also recorded 21 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.

PDUFA dates in July 2021

No PDUFA dates are disclosed for this period as of November 16, 2026.

Download: CSV · JSON · iCal (next 30 days, CC BY 4.0) · Calendar API · All months

July 2021: other FDA decisions and filings

DateDrugCompanyEventIndicationStatusSource
July 1, 2021KEYTRUDA® (pembrolizumab)MRKLabel expansion—ApprovedopenFDA Drugs@FDA
July 9, 2021Tivicay (dolutegravir sodium)GSKLabel expansion—ApprovedopenFDA Drugs@FDA
July 9, 2021Juluca (dolutegravir sodium; rilpivirine hydrochloride)GSKLabel expansion—ApprovedopenFDA Drugs@FDA
July 9, 2021Darzalex Faspro (daratumumab and hyaluronidase-fihj)JNJLabel expansion—ApprovedopenFDA Drugs@FDA
July 9, 2021Armonair Respiclick (fluticasone propionate)TEVALabel expansion—ApprovedopenFDA Drugs@FDA
July 9, 2021Airduo Digihaler (fluticasone propionate; salmeterol xinafoate)TEVALabel expansion—ApprovedopenFDA Drugs@FDA
July 15, 2021Opdivo® (nivolumab)BMYLabel expansion—ApprovedopenFDA Drugs@FDA
July 16, 2021Fexinidazole (fexinidazole)SNYFDA approval—ApprovedopenFDA Drugs@FDA
July 21, 2021KEYTRUDA® (pembrolizumab)MRKLabel expansion—ApprovedopenFDA Drugs@FDA
July 22, 2021Dalvance (dalbavancin hydrochloride)ABBVLabel expansion—ApprovedopenFDA Drugs@FDA
July 22, 2021Byetta (exenatide synthetic)AZNLabel expansion—ApprovedopenFDA Drugs@FDA
July 28, 2021Botox Cosmetic (onabotulinumtoxina)ABBVLabel expansion—ApprovedopenFDA Drugs@FDA
July 28, 2021XPHOZAH® (tenapanor)ARDXComplete Response Letter—CRL issuedFDA Complete Response Letters
July 28, 2021Semglee (insulin glargine-yfgn)VTRSFDA approval—ApprovedopenFDA Drugs@FDA
July 29, 2021Nucala (mepolizumab)GSKLabel expansion—ApprovedopenFDA Drugs@FDA
July 29, 2021Uptravi (selexipag)JNJFDA approval—ApprovedopenFDA Drugs@FDA
July 29, 2021Vyvanse (lisdexamfetamine dimesylate)TAKLabel expansion—ApprovedopenFDA Drugs@FDA
July 30, 2021Saphnelo (anifrolumab-fnia)AZNFDA approval—ApprovedopenFDA Drugs@FDA
July 30, 2021Romidepsin (romidepsin)BMYLabel expansion—ApprovedopenFDA Drugs@FDA
July 30, 2021Adlyxin (lixisenatide)SNYLabel expansion—ApprovedopenFDA Drugs@FDA
July 30, 2021Micafungin In Sodium Chloride 0.9% (micafungin sodium)TEVAFDA approval—ApprovedopenFDA Drugs@FDA

July 2021: dated readouts

No events in this view.

Questions

What PDUFA dates are in July 2021?

0 PDUFA dates fell in July 2021. The FDA calendar also recorded 21 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.

Can these dates change?

Yes. The FDA can extend a review by three months after a major amendment, and it sometimes acts before the goal date. Each row links the filing the date came from.

Built from primary public sources only: sponsor SEC filings (8-K, EX-99.1, 10-Q, 10-K), the FDA advisory committee calendar, FDA Novel Drug Approvals and Complete Response Letter records, openFDA, and ClinicalTrials.gov (U.S. National Library of Medicine). Every row links the sentence it came from. Dates move; the linked source is authoritative. Not investment or medical advice.

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.